Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Eamonn M.M. Quigley

doi:10.1016/j.gtc.2010.12.009

Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Eamonn M.M. Quigley

Research output: Contribution to journal › Review article › peer-review

58 Scopus citations

Abstract

Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.

Original language	English (US)
Pages (from-to)	207-222
Number of pages	16
Journal	Gastroenterology Clinics of North America
Volume	40
Issue number	1
DOIs	https://doi.org/10.1016/j.gtc.2010.12.009
State	Published - Mar 2011

Keywords

Anti-inflammatories
Antibiotics
Gut microbiota
Prebiotics
Synbiotics

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.gtc.2010.12.009

Cite this

@article{f8b61335bf4a4a8fbeca17163ebefbcc,

title = "Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies",

abstract = "Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.",

keywords = "Anti-inflammatories, Antibiotics, Gut microbiota, Prebiotics, Synbiotics",

author = "Quigley, {Eamonn M.M.}",

year = "2011",

month = mar,

doi = "10.1016/j.gtc.2010.12.009",

language = "English (US)",

volume = "40",

pages = "207--222",

journal = "Gastroenterology Clinics of North America",

issn = "0889-8553",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Therapies Aimed at the Gut Microbiota and Inflammation

T2 - Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

AU - Quigley, Eamonn M.M.

PY - 2011/3

Y1 - 2011/3

N2 - Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.

AB - Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.

KW - Anti-inflammatories

KW - Antibiotics

KW - Gut microbiota

KW - Prebiotics

KW - Synbiotics

UR - http://www.scopus.com/inward/record.url?scp=79951570315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951570315&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2010.12.009

DO - 10.1016/j.gtc.2010.12.009

M3 - Review article

C2 - 21333908

AN - SCOPUS:79951570315

SN - 0889-8553

VL - 40

SP - 207

EP - 222

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

IS - 1

ER -

Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this